Is the C-terminal flanking peptide of rat cholecystokinin double sulphated?  by Adrian, T.E. et al.
Volume 196, number 1 FEBS 3340 February 1986 
Is the C-terminal flanking peptide of rat cholecystokinin 
double sulphated? 
T.E. Adrian, J. Domin, A.J. Bacarese-Hamilton and S.R. Bloom* 
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London WI2 OHS, England 
Received 27 November 1985 
A specific radioimmunoassay was developed to the predicted nine amino acid C-terminal flanking peptide 
of cholecystokinin (peptide serine serine, PSS). In aqueous extracts of rat brain, PSS was undetectable unless 
the extracts were first treated with arylsulphatase, which also resulted in desulphation of cholecystokinin. 
The reverse-phase HPLC analysis of partially desulphated extracts showed the presence of two peaks inter- 
mediate to the naturally occurring and the completely desulphated forms. It is therefore proposed that the 
CCK-flanking peptide PSS has both tyrosine residues ulphated. 
Cholecystokinin Flanking peptide Radioimmunoassay (Rat brain) Desulfation HPLC 
1. I~RODU~ION 
The structure of rat pre-pro-cholecystokinin was 
recently elucidated from cloned mRNA [ 1,2]. The 
known sequence of cholecystokinin is flanked at 
the C-terminal end by a 12-amino-acid residue 
(Gly-~g-Arg-Ser-~a-Glu-up-Tyr-Glu-Tyr-Pro- 
Ser). It is likely that the first 3 amino acids would 
be lost following cleavage and that a nonapeptide 
(peptide serine serine, PSS) would be produced. 
All the naturally occurring forms of cho- 
lecystokinin have a sulphated tyrosine residue, 
which is essential for biological activity 131. Failure 
to detect PSS immunologically unless first treated 
with arylsulphatase uggests possible sulphation of 
its tyrosine residues. 
2. MATERIALS AND METHODS 
The whole brain from 200 g Wistar rats was 
rapidly removed after decapitation and immediate- 
ly minced and extracted by plunging into water 
(10 ml/g) containing 65 mM dithiothreitol (DTT) 
in a vigorously boiling water bath 141. After 
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m~nten~ce at 100°C for 10 min the extracts were 
cooled, centrifuged and partially purified by 
loading 5 ml onto reverse-phase octadecylsilica 
cartridges (Sep-Pak, Waters), washing with 20 ml 
water and eluting with 2 ml of 40% ace- 
ton&rile/water containing 0.05% trifluoroacetic 
acid (TFA) and 65 mM DTT. The eluate was then 
diluted to give a final acetonitrile concentration of
8% and possible particulate matter removed by 
centrifugation at 12000 x g for 5 min. 1 ml of this 
extract was incubated with 100~1 of 2 M acetate 
buffer (pH 5.0) and 2.5 mg arylsulphatase (Sigma 
8629) dissolved in 500 ,rrl of 0.2% sodium chloride 
for 2 h at 37°C. A second aliquot was treated iden- 
tically but with one-tenth the amount of 
arylsulphatase (250 pg) and incubated for only half 
the time (1 h). 
Samples of both extracts treated with 
~ls~phat~e and the untreated extract were sub- 
ject to reverse-phase high-pressure liquid 
chromatography (HPLC) on a 5 pm techsil Cl8 
column eluted at 1 ml per min with 
water/acetonitrile containing O.OSofo TFA and 
65 mM DTT. The column was first eluted with 
10% acetonitrile for 10 min and then a gradient 
was developed from 10 to 13% acetonitrile over 
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60 min. This was followed after 2 min at 13% 
acetonitrile with a gradient from 13 to 25% over 
10 min and then after 2 min at 26% with a gra- 
dient from 26 to 29%, followed by 2 min at 29070, 
then a gradient from 29 to 42% acetonitrile. Frac- 
tions (2 ml) were collected and 1 ml of each was 
treated with 100~1 of 2 M sodium acetate buffer 
(PH 5.0) and 250 pg arylsulphatase dissolved in 
100 pl of 0.2% sodium chloride and the whole in- 
cubated at 37°C for 2 h. 
PSS concentrations were measured using an an- 
tiserum (PSS4) raised in a rabbit immunized with 
synthetic non-sulphated PSS (2 pmol) conjugated 
with glutaraldehyde to bovine serum albumin 
(0.5 pmol). Rabbits received a primary immuniza- 
tion of 200 nmol conjugated PSS in 2 ml Freund’s 
complete adjuvant and 8 boosts of 50 nmol con- 
jugated PSS at monthly intervals. 
Non-sulphated synthetic PSS (2 nmol) was 
iodinated by conventional chloramine-T oxidation 
using 0.4 nmol Na”‘I (Amersham IMS 30) and 
70 nmol chloramine-T over 10 s. The product was 
purified by isocratic elution on a 5 pm techsil C-l 8 
(HPLC technology) column with 13% acetonitrile 
in water containing 0.05% TFA. The specific ac- 
tivity of iodinated PSS measured by self- 
displacement was 75 Bq - fmol-‘. The brain extract 
column eluants were assayed in 0.8 ml of 0.5 M 
phosphate buffer (pH 7.4) containing 0.15 mM 
bovine albumin, 2 fmol labelled PSS and an- 
tiserum at a final dilution of 1:24000. After in- 
cubation at 4°C for 5 days the free peptide was 
separated from bound by the addition of 4 mg 
charcoal (Norit GSX, BDH) with 4OOpg dextran 
(7OT, Sigma) in 0.5 ml assay buffer followed by 
centrifugation. The assay was capable of detecting 
changes between adjacent tubes of 10 fmol non- 
sulphated PSS with 95% confidence. C-terminal 
CCK-like immunoreactivity was measured using 
an antiserum (02) which fully reacted with all 
molecular forms of CCK, both sulphated and non- 
sulphated [5]. Specific measurement of sulphated 
natural CCK-8 was made using an antiserum 
(OTlO) which did not cross-react with non- 
sulphated CCK-8 [6]. 
3. RESULTS 
Concentrations of PSS-like immunoreactivity, 
C-terminal CCK-like immunoreactivity (total 
6 
CCK) and sulphated CCK-8 specific immunoreac- 
tivity are shown in table 1. It is notable that in the 
untreated aqueous extract the concentrations of C- 
terminal CCK-like immunoreactivity and sul- 
phated CCK-8 specific immunoreactivity are 
similar, whereas PSS is undetectable. In 
arylsulphatase-treated extracts the C-terminal an- 
tibody detects similar concentrations of CCK to 
those in untreated extracts whereas CCK-8 
sulphated concentrations are much lower. PSS-like 
immunoreactivity is revealed in arylsulphatase- 
treated extracts in molar quantities which are 
similar to those of sulphated CCK-8 in untreated 
extracts. 
The nature of the presumed sulphated PSS-like 
immunoreactivity both untreated and treated with 
low-dose and high-dose arylsulphatase was further 
investigated using reverse-phase HPLC. The high- 
dose arylsulphatase, which resulted in complete 
desulphation of CCK-8, gave a peak of PSS-like 
immunoreactivity in the same position as synthetic 
non-sulphated PSS standard (fig.1). In the same 
column run C-terminal CCK-like immunoreactivi- 
ty eluted in the position of non-sulphated CCK-8 
but this peak was not detected by the specific 
sulphated CCK-8 assay. When untreated aqueous 
rat brain extracts were columned PSS-like im- 
Table 1 
Immunoreactive PSS, C-terminal CCK and specific 
sulphated CCK-l-like immunoreactivity in aqueous 
extracts of rat brain before and after treatment with 
arylsulphatase 
CCK-8 
(nmol/z) 
PSS 
(nmol/a) 
Untreated 79.4 f 6.1 nil detected 
Sulphatase-treated 
(complete) 4.1 f 1.3 72.2 f 5.9 
Untreated 76.6 f 5.8 nil detected 
Sulphatase-treated 
(mild) 27.7 f 2.4 41.5 f 6.8 
Concentrations of CCK-8 were measured with specific 
antibody (OTlO) and non-sulphated PSS with antibody 
PSS 4 in aqueous extracts of rat brain before and after 
complete and mild desulphation (mean * SE, n = 10 per 
group) 
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Fig.1. The top panel shows the elution profile of Fig.2. Reverse-phase HPLC showing effect of mild 
aqueous rat brain extract. P&like immunoreactivity desulphation of PSS and CCK-8 in an aqueous rat brain 
(PSS4) is revealed in the desulphated extracts only and extract. This was carried out as in fig. 1. In the top panel 
depicted by the open bars. C-terminal CCK-like the brain extract was columned without prior sulphatase 
immunoreactivity (02), also detected in these extracts, is treatment. In the bottom panel the extract was subjected 
shown in the hatched bars. The antibody specific for to mild sulphatase pre-treatment before columning. PSS 
sulphated CCK-8 (OTlO) only detected the CCK peak in immunoreactivity (open bars) eluted in 4 peaks after this 
non-sulphatase-treated column fractions. The bottom mild pretreatment of extract with sulphatase. Some C- 
panel shows the elution profile of the same aqueous terminal CCK-like immunoreactivity was also generated 
brain extract as- above, pre-treated with arylsulphatase and eluted in the position of non-sulphated CCK, but 
before columning. Sulphated CCK-8 was not detected in this peak was not seen by the specific anti-sulphated 
this pretreated extract column using antibody OTlO. CCK-8 antibody even in untreated column fractions. 
munoreactivity was only revealed when column 
fractions were subsequently treated with 
arylsulphatase. The immunoreactivity thus de- 
monstrated eluted earlier (fraction 16) than the 
synthetic non-sulphated PSS standard (fraction 
27). 
Similarly, CCK-like immunoreactivity eluted 
earlier (fraction 59) compared with the position of 
the peak when extract treated with arylsulphatase 
before columning. was analysed (fraction 63). 
When low-dose arylsulphatase pre-treatment of 
brain extracts was examined only a partial 
desulphation of CCK-8 was observed (fig.2). 
Under these conditions 4 peaks of immunoreactive 
PSS became apparent, the fractions all being 
treated after columning with arylsulphatase. The 
first peak appeared in the position of natural PSS 
(fraction 16) as seen in untreated extracts. Two 
small peaks then preceded the final peak which 
itself eluted in the position of the pure synthetic 
PSS standard. 
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4. DISCUSSION 
These studies thus suggest he existence in rat 
brain of the predicted C-terminal flanking peptide 
of CCK-8, denoted here as PSS. The finding that, 
at a concentration of arylsulphatase sufficient to 
desulphate CCK-8 only partially, PSS im- 
munoreactivity eluted in 4 separate positions on 
HPLC suggests the possibility that both tyrosines 
are sulphated. Thus the product presumably was a 
mixture of double-sulphated PSS, Tyr 5 sulphated 
PSS, Tyr 7 sulphated PSS and desulphated PSS. 
Sulphation is now thought to be a widespread 
post-translational modification of peptides and 
proteins and is sometimes essential for biological 
activity, as in the case of cholecystokinin [7,8]. It 
is notable that a sulphated tyrosine residue is in- 
variably preceded by an acidic region in the peptide 
sequence and most often the tyrosine itself follows 
an aspartate or glutamate residue (J.E. Dixon, per- 
sonal communication). This acidic region may 
7 
Volume 196, number 1 FEBS LETTERS February 1986 
prove to be an important recognition site for the 
cellular sulphotransfer~e involved. 
In PSS both tyrosine residues are preceded by 
acidic amino acids in the sequence. It is of some in- 
terest that the sequence Glu-Asp-Tyr-Glu-Tyr in 
PSS is identical to residues 1397-1401 of comple- 
ment component C4 which is also sulphated on 
these two tyrosine residues [9]. 
Recently, the predicted sequence for human pre- 
pro-cholecystokinin was reported and the C- 
terminal flanking region of this molecule was 
found to be closely identical to that of the rat, dif- 
fering only in a glutamate substitution for aspar- 
tate at position 4, retaining, unchanged, the acidic 
arrangement of the molecule [lo]. Indeed this C- 
flanking region of cholecystokiuin has close se- 
quence simil~ties with the C-flanking region of 
pre-pro-gastrin. It has become commonplace to 
find that more than one biologic~ly active peptide 
is coded for in a single messenger RNA sequence 
[il-131. As the C-flanking sequence of 
chol~ystoki~n appears to be highly conserved 
between man and rat and is sulphated in a similar 
manner to cholecystoki~n (where the sulphate 
group is essential for biological activity), it is 
tempting to speculate that PSS may also be found 
to have a significant biological role. 
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